Rocky Road for Intuitive Surgical, yet Share Price Due to Rise
The recent probe by U.S Regulators to investigate the cause of adverse incidents has also contributed to Intuitive's share decline.
(March 19, 2013)
Da Vinci: Surgical Robot Maker Faces Lawsuits
Quarterly sales rose 23 percent to $609 million yet lawsuits and potential lawsuits keep mounting.
(February 08, 2013)
iRobot Stock Spikes as Company Reaches New Milestones
iRobot's RP-VITA receives FDA clearance, new 3-D printing patent in the works
(January 25, 2013)
The IP Battle Continues for Robotics Companies
Patent attorney, C. Andrew Keisner responds to questions raised by VGo and InTouch Health's recent patent dispute.
(January 07, 2013)
Uncle Sam Taxing Medical Robotics in 2013
Patient Protection and Affordable Care Act's 2.3% excise tax on medical device revenues slated to hit next year.
(December 10, 2012)
Dueling Surgical Robots: da Vinci vs. SPRINT
New surgical robot developed as part of the $10 million (EUR 8.1 million), European Commission funded Araknes project.
(November 20, 2012)
Hansen Medical Capitalizes on Patent Portfolio to the Tune of $20M
Intuitive Surgical also purchased $10M in Hansen Medical stock
(November 09, 2012)
Motley Fool Ranks Robot Surgicals
It’s still very early, but initial interest in Intuitive’s single site product for general surgery appears strong; as Intuitive’s management stated, the device is already in more than 200 U.S. hospitals.
(September 19, 2012)
Robotic Surgery Market Report—2012
The global market for robotic surgeries is poised to achieve sizeable growth in the times to come, replacing the traditional methods of invasive surgery.
(September 19, 2012)
Florida’s NCSA Invests Millions In Robotic Surgery Training and Latency Research
The center’s partnership with Mimic Technologies tests the value of robotic surgery simulation while stimulating the local economy
(July 30, 2012)
U.S. Medical Robotics Market to Reach $1.53B by 2018
Robotics technology has evolved from providing limited medical care to offering a broad range of functions including patient rehabilitation and surgical procedures with more efficacy and competence.
(July 20, 2012)
Thinking Twice On Rethink Robotics
According to expert analyst Dan Kara, Rethink Robotics is very well positioned, in terms of executive leadership, financing and first-to-market advantage to monopolize the market for its unique class of manufacturing robots for the foreseeable future.
(June 25, 2012)
Intuitive: Share Price Stratospheric, Yet Questions Linger
Management expects growth of 25 percent to 27 percent in procedures, up from the previously forecast 24 percent to 26 percent. Also impressive were sales of 140 Da Vinci systems for the quarter compared to 120 during the same period last year and 126 forecast by JMP Securities. Whopping year-on-year increase of $107.10 million.
(May 09, 2012)